Policy & Regulation
MEDSIR names new chief business officer
23 September 2022 -

MEDSIR, a Spain-based international company specialised in the strategic design of clinical trials, announced on Thursday that it has named Jyoti Mundra, PhD as its new chief business officer.

In the new role, Dr Mundra is to provide support in expediting the company's growth while improving its presence and business in North America. She will be heading a global business and marketing team to provide clinical solutions to biopharma companies and build a network with hospitals and institutions.

Dr Mundra has served at various full service CRO's, supporting biopharma companies to advance their drug pipeline. She has held the position of a director of Business Development at Sinclair Research. She also served in similar roles at Champions Oncology and Covance.

Login
Username:

Password: